James J. Burns & Company LLC Increases Stock Position in iShares Biotechnology ETF (NASDAQ:IBB)

James J. Burns & Company LLC grew its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 20.4% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,051 shares of the financial services provider’s stock after buying an additional 347 shares during the period. James J. Burns & Company LLC’s holdings in iShares Biotechnology ETF were worth $298,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in IBB. Clarity Capital Partners LLC purchased a new stake in iShares Biotechnology ETF in the third quarter worth $206,000. Quintet Private Bank Europe S.A. increased its stake in shares of iShares Biotechnology ETF by 20.7% in the 3rd quarter. Quintet Private Bank Europe S.A. now owns 14,752 shares of the financial services provider’s stock worth $2,148,000 after acquiring an additional 2,533 shares in the last quarter. Kanawha Capital Management LLC lifted its position in iShares Biotechnology ETF by 20.6% during the 3rd quarter. Kanawha Capital Management LLC now owns 8,384 shares of the financial services provider’s stock valued at $1,221,000 after acquiring an additional 1,432 shares during the period. Blue Square Asset Management LLC boosted its stake in iShares Biotechnology ETF by 3.0% during the third quarter. Blue Square Asset Management LLC now owns 19,902 shares of the financial services provider’s stock worth $2,898,000 after acquiring an additional 580 shares in the last quarter. Finally, Realta Investment Advisors grew its holdings in iShares Biotechnology ETF by 306.8% in the third quarter. Realta Investment Advisors now owns 4,117 shares of the financial services provider’s stock worth $600,000 after purchasing an additional 3,105 shares during the period. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

NASDAQ:IBB opened at $142.85 on Tuesday. The firm has a 50-day simple moving average of $145.02 and a two-hundred day simple moving average of $140.57. iShares Biotechnology ETF has a fifty-two week low of $113.56 and a fifty-two week high of $150.57.

iShares Biotechnology ETF Announces Dividend

The firm also recently declared a dividend, which was paid on Monday, September 30th. Stockholders of record on Wednesday, September 25th were paid a dividend of $0.2005 per share. The ex-dividend date of this dividend was Wednesday, September 25th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.